|
In its press release on 20 March 1987, the day AZT was licensed as an AIDS drug, the FDA stated: ‘Retrovir was originally developed in 1964 by Dr. Jerome Horowitz [sic] of the Michigan Cancer Foundation as a possible treatment for cancer.’;
|
www.tig.org.za/pdf-files/inventing_azt.pdf
www.tig.org.za/pdf-files/inventing_azt.pdf
|
|
|
|
Nine percent of the patients who were not treated with AZT developed the symptoms of AIDS within a year, while only half of the AZT-treated group developed symptoms. However, after reviewing the data from the US trial, European researchers decided to continue a similar drug trial that has been going on in Europe.
|
www.faqs.org/abstracts/Science-and-technology/AZT-still...
www.faqs.org/abstracts/Science-and-technology/AZT-still-on-trial-East-Germany-struggles-to-clean-its-air-and-water.html
|
|
|
AIDSmeds.com is dedicated to providing people living with HIV the necessary information they need to make empowered treatment decisions. ... 5th IAS Conference on HIV Pathogenesis Treatment and Prevention; Cape Town, South Africa; July 19-22, 2009; ... more conference coverage...
|
WASHINGTON - Announcing a significant advance in the battle against AIDS, federal health officials said Thursday that the antiviral drug AZT has been shown to delay onset of the disease in certain groups of infected patients who have not yet developed symptoms. ... AZT, or zidovudine, was approved by the Food and...
|
www.aegis.com/news/lt/1989/LT890806.html
|
|
This study documents mother-to-child transmission of AZT-resistant HIV-1 from mothers with high viral loads who developed AZT resistance during pregnancy. These data illustrate that assay of plasma HIV-I RNA level and AZT resistance by PCR may help to monitor the efficacy of antiviral therapy during pregnancy.
|
www.aegis.com/conferences/croi/1996/132.html
|
|
Anemia with hemoglobin levels below 7.5 g per deciliter developed in 24 percent of AZT recipients and 4 percent of placebo recipients (P less than 0.001). Twenty-one percent of AZT recipients and 4 percent of placebo recipients required multiple red-cell transfusions (P less than 0.001). Neutropenia (less than 500 cells...
|
www.medscape.com/medline/abstract/3299090
|
|
The South African president, Thabo Mbeki, and the minister of health, Dr Manto Tshabalala-Msimang, have deepened a political storm about the well known antiviral drug zidovudine (AZT), developed and marketed by Glaxo-Wellcome.
|
www.bmj.com/cgi/content/extract/319/7224/1522/g
|
|
Despite the over 100,000 papers published on HIV and AIDS, the AIDS establishment has never been able to demonstrate that even a small group of healthy HIV-positive Americans or Europeans, who had neither used recreational drugs nor antiviral drugs such as AZT ever developed AIDS (225). No controlled study in the...
|
www.virusmyth.com/aids/hiv/pddrdrugaids6.htm
|
|
Half the patients in the study took AZT and the rest took a dummy pill. So far, 36 patients taking the inert substance have progressed to full-fledged AIDS but only 14 of those taking AZT developed the full disease.
|
www.nytimes.com/library/national/science/aids/080489sci...
www.nytimes.com/library/national/science/aids/080489sci-aids.html
|
|
